COVID-19 news from experts at Columbia University Irving Medical Center. Visit our Coronavirus Resource Center for the latest COVID-19 information for CUIMC providers, staff, students, researchers and patients. If you are a member of the media and would like to receive CUIMC COVID-19 Advances, a tip sheet for journalists produced by the CUIMC Office of Communications, please email CUMCNews@cumc.columbia.edu with the subject line "CUIMC COVID-19 Advances."
Search All News
Based on their experience treating COVID-19, Columbia physicians have assembled critical information about the coronavirus’s effects on organs outside the lungs.
A video that chronicles the medical school’s response to COVID-19 illustrates how the entire Columbia community came together to confront the most challenging health crisis of our time.
A new study compares different NYC reopening scenarios and suggests that keeping all industries, including schools, at 50% capacity may keep COVID-19 at relatively low levels through May 2021.
Mailman researchers estimate that the overall COVID-19 fatality rate in New York City is 1.45%, twice that of estimates from other countries, and older adults have the greatest mortality risk.
- March 24, 2020
Data scientists from Columbia University and around the world are starting to use the world’s electronic health records and databases to identify the best therapies for treating COVID-19 patients.
- March 23, 2020
CUIMC psychologist Anthony Puliafico offers some helpful advice for practicing self-care, helping patients problem solve, and not worrying yourself sick.
- March 16, 2020
The explosion of COVID-19 cases in China was largely driven by people with mild or no symptoms who went undetected, according to a new study from Columbia University Mailman School of Public Health.
- March 5, 2020
The National Institutes of Health has provided the Center for Infection and Immunity live SARS-CoV-2 samples to use in research to develop rapid tests and identify sources of transmission.
- February 20, 2020
Four research teams at Columbia University will share a $2.1 million grant to mount an aggressive effort to identify potential antiviral drugs and antibodies for use against the new coronavirus.